Sign In
Buy HCA
$361.83
-1.40 (-0.385%)
At Close: Jun 04, 2026
Reasons to Retain HCA Healthcare (HCA) Stock in Your Portfolio
10:31am, Thursday, 28'th Dec 2023
HCA Healthcare's (HCA) improving top line, acquisition initiatives and a robust growth outlook poise the company well for growth.
HCA Healthcare (HCA) Rises Higher Than Market: Key Facts
06:47pm, Tuesday, 19'th Dec 2023
In the most recent trading session, HCA Healthcare (HCA) closed at $269.18, indicating a +0.75% shift from the previous trading day.
HCA Healthcare, Inc. (HCA) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Friday, 15'th Dec 2023
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
HCA Healthcare (HCA) Beats Stock Market Upswing: What Investors Need to Know
06:47pm, Monday, 11'th Dec 2023
HCA Healthcare (HCA) closed the most recent trading day at $262.02, moving +1.74% from the previous trading session.
HCA Healthcare's (HCA) Houston Affiliate Acquires 11 EDs
12:02pm, Tuesday, 05'th Dec 2023
The deal helps HCA Healthcare (HCA) boost its freestanding EDs in the Houston region to 26, supplementing its existing hospital-based emergency rooms.
HCA Healthcare (HCA) Increases Despite Market Slip: Here's What You Need to Know
06:47pm, Monday, 04'th Dec 2023
HCA Healthcare (HCA) concluded the recent trading session at $257.14, signifying a +1.89% move from its prior day's close.
Investors Heavily Search HCA Healthcare, Inc. (HCA): Here is What You Need to Know
10:31am, Friday, 01'st Dec 2023
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 Healthcare Stocks That Could Help Set You Up for Life
07:00am, Saturday, 25'th Nov 2023
Vertex Pharmaceuticals is an innovative biotech with a robust portfolio and rich pipeline. HCA Healthcare leads an area of the healthcare industry that isn't easy to break into now.
HCA Remains Attractive Despite A JV Misstep
05:11pm, Monday, 20'th Nov 2023
HCA Healthcare's shares have risen 8% from last year but fallen 15% from their summer high. The company's earnings have undershot expectations due to slower margin recovery and a joint venture mishap.
HCA Healthcare (HCA) Unveils Ambitious 5-Year Growth Targets
12:47pm, Monday, 13'th Nov 2023
Over the five-year horizon, HCA Healthcare (HCA) anticipates substantial 8-12% annual growth in earnings per share.
HCA Healthcare sets EPS growth target of 8% to 12% for the next five years
07:39am, Thursday, 09'th Nov 2023
HCA Healthcare Inc. HCA, -0.67% said Thursday it's targeting per-share earnings growth of 8% to 12% for the next five years. The hospital operator offered the forecast in a statement released ahead of
HCA Healthcare to Present at November Healthcare Conference
04:30pm, Monday, 06'th Nov 2023
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference: November 14, 2023 at 11:45am EST at the 2023 Wolfe Healthcare Confer
3 Sector ETFs & Stocks to Gain Despite Soft Jobs Data
09:01am, Monday, 06'th Nov 2023
The U.S. economy added 150,000 jobs in October 2023, below market forecasts of 180,000.
Here is What to Know Beyond Why HCA Healthcare, Inc. (HCA) is a Trending Stock
10:34am, Thursday, 02'nd Nov 2023
HCA (HCA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
HCA Healthcare, Inc. (HCA) Q3 2023 Earnings Call Transcript
01:43pm, Tuesday, 24'th Oct 2023
HCA Healthcare, Inc. (NYSE:HCA ) Q3 2023 Earnings Conference Call October 24, 2023 10:00 AM ET Company Participants Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Frank
